financetom
Business
financetom
/
Business
/
Why Jaguar Health Stock Is Tanking
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Jaguar Health Stock Is Tanking
May 20, 2024 9:31 AM

Jaguar Health, Inc. ( JAGX ) shares are falling Monday after the company announced a 1-for-60 reverse stock split.

The Details:

The company will effect a reverse stock split at an exchange ratio of 1-for-60, on Thursday, in order to support the company’s compliance with Nasdaq’s listing standards.

“Jaguar’s board of directors has determined that effecting a reverse stock split at this time will, in addition to supporting the Company’s compliance with Nasdaq’s listing standards, provide Jaguar with the opportunity to achieve a share price and outstanding share count that is more attractive to institutional investors,” said Lisa Conte, Jaguar’s CEO.

Last week, Jaguar reported worse-than-expected first-quarter results with losses of 6 cents per share, compared to the losses of 3 cents per share analyst estimate. Quarterly sales also came in below the consensus estimate at $2.351 million. 

Related News: What’s Going On With Faraday Future Stock Today?

JAGX Stock Prediction 2024:

Equity research analysts on and off Wall Street typically use earnings growth and fundamental research as a form of valuation and forecasting. But many in trading turn to technical analysis as a way to form predictive models for share price trajectory.

Some investors look to trends to help forecast where they believe a stock could trade at a certain point in the future. Looking at Jaguar Health ( JAGX ), an investor could make an assessment about a stock's long term prospects using a moving average and trend line. If they believe a stock will remain above the moving average, which many believe is a bullish signal, they can extrapolate that trend into the future using a trend line. For Jaguar Health ( JAGX ), the 200-day moving average sits at $0.23, according to Benzinga Pro, which is above the current price of $0.14. For more on charts and trend lines, see a description here.

Traders believe that when a stock is above its moving average, it is a generally bullish signal, and when it crosses below, it is a more negative signal. Investors could use trend lines to make an educated guess about where a stock could trade at a later date if conditions remain stable.

JAGX Price Action: According to Benzinga Pro, Jaguar Health ( JAGX ) shares are down 42.5% at 14 cents at the time of publication Monday.

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Consulting Companies Face US Government Threat of Contract Terminations
Market Chatter: Consulting Companies Face US Government Threat of Contract Terminations
Apr 9, 2025
02:10 PM EDT, 04/09/2025 (MT Newswires) -- Booz Allen Hamilton Holding ( BAH ) , Accenture ( ACN ) , IBM ( IBM ) and other large consulting groups faced accusations of financial obfuscations from the Trump administration during contracts reviews, with threats to recompete long-standing agreement, the Financial Times reported Wednesday, citing a letter to the companies from the...
US corporate bond market dries up on Trump tariff volatility
US corporate bond market dries up on Trump tariff volatility
Apr 9, 2025
* U.S. corporate bond market quiets on tariff war, Treasury market volatility * Bond spreads widen most in week after tariffs since first week of March 2023 regional bank stress * Five to six companies stay on sidelines after volatility, syndicate banker says (Updates with market commentary and Treasury auction results) By Matt Tracy April 9 (Reuters) - U.S. corporate...
EXPLAINER-Prescription drugs become a target in Trump's trade war
EXPLAINER-Prescription drugs become a target in Trump's trade war
Apr 9, 2025
LONDON, April 9 (Reuters) - U.S. President Donald Trump late on Tuesday reiterated he would impose tariffs on imports of pharmaceutical products that have long been spared from past trade disputes due to the potential for harm to patients. Trump excluded them from his announcement of sweeping import tariffs last week, but in recent weeks he introduced tariffs on raw...
Joseph Rallo's EF Hutton returns to Wall Street
Joseph Rallo's EF Hutton returns to Wall Street
Apr 9, 2025
(Reuters) - EF Hutton said on Wednesday it is making a comeback to Wall Street, reviving one of the most prominent brands in the brokerage industry. It will be led by CEO Joseph Rallo, who, along with former business partner David Boral, had previously resurrected the brand in 2021. Rallo and Boral positioned EF Hutton at the center of Wall...
Copyright 2023-2025 - www.financetom.com All Rights Reserved